Sign In
Buy UBS
$53.46
+0.710 (+1.35%)
At Close: Aug 04, 2026
Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2022
02:30pm, Tuesday, 26'th Jul 2022 Benzinga
Upgrades
For Agile Therapeutics Inc (NASDAQ:AGRX), Maxim Group upgraded the previous rating of Hold to Buy. For the first quarter, Agile Therapeutics had an EPS of $3.78, compared to year-ago quarter
UBS' Q2 Earnings Improve Y/Y on Higher NII, Lower Costs
02:00pm, Tuesday, 26'th Jul 2022
Higher revenues and lower expenses support UBS' Q2 earnings.
UBS (UBS) Q2 Earnings and Revenues Lag Estimates
11:05am, Tuesday, 26'th Jul 2022 Zacks Investment Research
UBS (UBS) delivered earnings and revenue surprises of -1.61% and 5.33%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
UBS Group AG (UBS) CEO Ralph Hamers on Q2 2022 Results - Earnings Call Transcript
10:28am, Tuesday, 26'th Jul 2022
UBS Group AG (NYSE:UBS ) Q2 2022 Earnings Conference Call July 26, 2022 3:00 AM ET Company Participants Sarah Mackey - Head, IR Ralph Hamers - Group CEO & President, Group Executive Board Sarah Youngw
UBS (UBS) Q2 Earnings and Revenues Lag Estimates
08:32am, Tuesday, 26'th Jul 2022
UBS (UBS) delivered earnings and revenue surprises of -1.61% and 5.33%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Why Macy's Is Up 10% This Week
06:39pm, Friday, 22'nd Jul 2022 The Motley Fool
The iconic department store chain unveiled a couple of strategic updates, although neither overcomes its bigger challenges.
Deutsche Bank (DB) Earnings Expected to Grow: Should You Buy?
02:01pm, Wednesday, 20'th Jul 2022 Zacks Investment Research
Deutsche Bank (DB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
This Financial Powerhouse Is Thriving Despite Market Volatility
09:15am, Wednesday, 20'th Jul 2022 The Motley Fool
This company continues to attract investors' money.
Inventory Woes Are a Boon for This Sliver of the Retail Industry
03:00pm, Tuesday, 19'th Jul 2022 The Motley Fool
The industry has a mechanism for getting rid of goods that can't be sold at the right price their first go-around.
UBS (UBS) Earnings Expected to Grow: Should You Buy?
02:01pm, Tuesday, 19'th Jul 2022 Zacks Investment Research
UBS (UBS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
UBS (UBS) Earnings Expected to Grow: Should You Buy?
11:37am, Tuesday, 19'th Jul 2022
UBS (UBS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
5 Big Investors Betting on Hydrogen Stocks
02:42pm, Friday, 15'th Jul 2022
Hydrogen stocks are falling lower after Senator Joe Manchin voiced his disapproval of federal funding for climate and energy programs. The post 5 Big Investors Betting on Hydrogen Stocks appeared firs
Criminal complaint filed against UBS over DRC-linked funds
10:48am, Friday, 08'th Jul 2022
Three organisations have filed a criminal complaint to federal prosecutors in Switzerland, alleging possible money laundering and a failure to exercise due diligence at UBS in relation to funds they s
Why Kohl's Stock Bounced Back on Tuesday
09:38pm, Tuesday, 05'th Jul 2022 The Motley Fool
Investors are seeing a light at the end of the tunnel, despite a trio of analyst price target cuts.
A Trio of Stocks Trading Below DCF Value
07:13pm, Sunday, 03'rd Jul 2022
When screening the market for bargains, investors may want to consider the following stocks, since their share prices are trading below or around the intrinsic value calculated by GuruFocus' free cash
